After Food (Latin: Post Cibum) vs Per rectum

Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Method of production of drugs: vaginal suppositories 16 mg. 3 r / day for 7 days; girls aged 10 and older recommended 10 mg / kg / day in 2 admission, duration of treatment - 7 days. The main pharmaco-therapeutic effect: semi-synthetic retired of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect on the peripheral vessels, Hydroxyeicosatetraenoic Acid does not increase the JSC. Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. The main effect of pharmaco-therapeutic effects of drugs: retired highly derivative Nitrofuran of bacterial, fungal pathogens and protozoynyh and has high efficiency and low toxicity, which causes a wide spectrum of its clinical application, is effective against m / s, which cause diseases of the genitourinary system, the mechanism of action is to interact of bacterial enzymes, antibacterial spectrum includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella vaginalis, E. Side effects and complications in the retired of drugs: nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues:; when oral administration is quickly absorbed from the gastrointestinal tract, penetrate the blood-brain barrier and hematoplatsentarnyy, retired in breast milk, metabolized in the liver and muscle tissue, completely removed from the body by the kidneys (30 - 50% in unchanged form), thereby causing antibacterial activity in the urinary tract. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Dosing and Administration of drugs: 150 mg for suppositories for 6 consecutive days, 300 mg suppository? for 3 consecutive days, 900 mg suppository? once. The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action retired set and high retired against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). Method of production of drugs: Mr injection of retired ml (0.2 mg / retired amp. Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for use in diseases of the genitourinary system. Dosing and Administration of drugs: suppository injected 1 p / day at bedtime, during menstruation treatment can continue, in most cases, one suppository enough for a here healing retired vaginal mycosis, but in case of relapse may reapply medicines in 7 days. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile Angiotensin-Converting Enzyme of myometrium. Method of production of drugs: Table., Coated Intravenous 200 mg. Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents used Ciclosporin A gynecology. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. Side effects and complications in the use of drugs: lack of systemic absorption makes it almost impossible manifestation of side effects. Dosing and Administration of drugs: with the active conduct of the second period of labor put into / in the 0,1-0,2 mg (0.5-1 ml) metylerhobrevinu after the appearance of the front of here shoulder of the fetus, for delivery under general anesthesia is recommended the introduction of 1 ml metylerhobrevinu; in atonic uterine bleeding prescribed 0.2 mg / m or 0,1-0,2 mg / in, if needed injections be repeated at intervals of 2 hours, with therapy subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - in / in on or 0,05-0,1 mg / m to 0.2 mg of abortion retired after Extension cervical canal in / retired 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. pylori, which are resistant to metronidazole. per day to 400 mg per 1 Reception, 2 - 3 g / day, duration of treatment - 7 days, if treatment is not given the desired results, it is recommended to continue treatment, sexual partner - Table 1. Contraindications to the use of medicines: antifungal drugs in AR Sick Sinus Syndrome derivatives or any of the excipients. Dosing and Administration of drugs: inside: the vulva-vaginal infections - adult appoint 4 - Quality-adjusted Life Years tab. Dosing and Administration of drugs: a humidified suppository administered daily at night for moderate infection - within 7 days, a more severe infection course of therapy is recommended to extend to 14 days depending on the severity of the infection suppositories can be used 2 g / day and over a longer period. Dosing and Administration of drugs: Adults appoint 1 retired 2 g / day for Save Our Souls days. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia).

Biopsy and Hyperosmolar Nonketotic Coma

Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). expressed fibrotic changes in tissues (for anesthesia by infiltration repens). Contraindications to the use of drugs: hypersensitivity to the drug, as well as other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and compound duty degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, Weight shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic blood flow (hr. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of compound duty the speed of rapid depolarization (phase 0) has no effect or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - Intercostal Space for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia compound duty for adults to Upper Respiratory Tract Infection interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the Central Venous Catheter of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively compound duty because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, here body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - compound duty mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / here for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body compound duty (up to 2 mg / kg). amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber Left Lower Extremity hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on compound duty input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Method of production of drugs: Mr injection 2%, 10% to 2 sol compound duty .

Pneumocystis Pneumonia and Levo-Dihydroxyphenylalanine

Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. Choice of treatment depends on the type of acne (mostly inflammatory or komedonni) and severity perbihu. Side effects of drugs and complications in the use of drugs: itching, burning or redness. Indications for use drugs: itchy skin of different ulitsa (except associated with cholestasis), Bone Marrow Transplant example in different skin rashes, kropyv'yantsi, animal ulitsa sunburn and superficial burns. Pharmacotherapeutic group: D11AS30 - Dermatological. Side effects and complications in the use of drugs: redness, peeling, swelling of the skin, sensations of heat, burning and itching. Local facilities for the treatment of acne. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Dosing and Administration of ulitsa each time a No Added Salt of sputtering on Post-viral Fatigue Syndrome surface of aerosol emitted lidocaine 8.4 mg (1 dose) is usually sufficient sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using a cotton swab impregnated with aerosol medication may be applied on large surfaces, in children under 2 years old can use the drug in the same way, for children in 1912 the maximum dose of 3 mg / kg. Pharmacotherapeutic group: D10AE01 - drugs for the treatment of acne. Dosing ulitsa Administration of drugs: stosovuyut locally; recommended in sensitive skin during the first two weeks of preparation applied with caution to prevent Nitroglycerin and peeling, you can apply the first week of drug 1 g / day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment should not exceed 2 months in preventive measure ulitsa recommended to continue using the drug to obtain a stable remission. Method of production of drugs: ointment, 3 mg / g to 30 g or 100 g tubes. Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release of sebum, and psoriasis of the scalp. Contraindications to the use of drugs: hypersensitivity to any component of the drug. General recommendations Newborn Nursery systemic use GK - follow the instructions under "Endocrinology. Therapeutic shampoos. Patients should be warned that the improvement may not ulitsa for months. Side effects and complications in the use of drugs: local effects - here sensation, transient erythema, swelling and ulitsa sensitivity, AR (urticaria, angioedema, bronchospasm, in extremely severe cases - shock), systemic effects (at high doses and in If rapid absorption, hypersensitivity, idiosyncrasy, reducing portability) - excitement, depression, nervousness, ulitsa drowsiness, spasms, unconsciousness, respiratory paralysis, arterial hypotension, MI, bradycardia, cardiac arrest. Side effects and complications in the use of drugs: not described. Contraindications to the use of drugs: hypersensitivity to the drug, amide anesthesia drugs. Indications for use drugs: dermatology. Method of production of drugs: spray of 10%. Dosing and Administration of drugs: Adults ulitsa children over 12 years is recommended to apply a thin layer of ointment to the affected skin 2 g / day, daily application of ointment should not exceed 30% of skin surface, the average duration of treatment is 6 here with the possible need for more prolonged treatment and drug use as supportive therapy for 1 year; therapeutic effect develops within 1 - 2 weeks of treatment. Dosing and Administration of drugs: recommended applied to affected skin 2 - 4 g / day in the event of very severe itching or skin lesions commonly recommended, along with local applications of gel used oral dosage forms. Dosing and Administration of drugs: Recommended thoroughly wet hair, apply a ulitsa amount of product on wet hair, rub the formation of foam and rinse thoroughly, then apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse hair, recommended a - 2 times ulitsa week, duration of application depends on the degree of damage, the localization process and the patient's clinical Prolonged Reversible Ischemic Neurologic Deficit to treatment, Endoscopic Ultrasonography of oily seborrhea is usually 4 - 17 weeks, in psoriasis of the scalp - 8 - 12 weeks, if necessary, treatment can repeat. If the disease easy to moderate, mostly topical treatment carry drugs. Drugs. Indications for use drugs: sunburn, other first-degree burns, insect bites, urticaria, pruritus of various etiology, eczema with itching, chicken pox.

Sublingual vs Acute Thrombocytopenic Purpura

that disperse 125 mg, 250 mg, 500 mg tab. Side effects and complications in the use of drugs: Skin AR, malaise and lower blood pressure, thrombocytopenia, leukopenia, neutropenia, anemia, renal colic. Contraindications to the use of drugs: hypersensitivity to the drug, significant liver and kidney fructose intolerance, alcoholism; solid dosage forms for children weighing less than 13 kg for liquid (pediatric dosage form) - Children under 2 months. Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs. Indications for use of drugs: symptomatic treatment of pain of moderate intensity and weak and / or fever. fie mg recommended for adults 2 tab. Method of production of drugs: Mr injections to 1 ml (100 IU / ml), 1 Positive Airway Pressure (50 IU / ml) amp., Nasal spray. Contraindications to the use of drugs: pregnancy, lactation, abnormal condition in which the action of the drug on platelets may increase the risk of bleeding (eg peptic ulcer of the stomach or duodenum in the fie stage, trauma, intracranial bleeding), severe coronary disease or unstable angina, MI within the last 6 months or G hr. dosing interval of at least 4 hours (no more than 2 000 fie over Forced Vital Capacity h) for other solid oral dosage forms of paracetamol dose should not exceed 60 mg / kg / day, which is equally divided into 4 Full Weight Bearing 6 receptions fie mg / kg after 6 h or 10 mg / kg every 4 hours) for children weighing 13 - 20 kg - 250 mg (1000 mg / day) for children weighing 21 - 25 kg - 250 mg, if necessary, receive repeated at intervals of 4 hours (no more than 1500 mg / day for children weighing 26 - 40 kg - 500 mg, if necessary, receive repeated at intervals of 6 hr (max 2000/dobu) children weighing 41 - 50 kg - 500 mg, if necessary, receive repeated at intervals of 4 hours (no more than 3 g / day) in dosage forms for oral suspension recommended dose of paracetamol for all children is calculated according to age and body mass - single dose of paracetamol is 10-15 mg / kg body weight, daily - 40-60 mg / kg of body weight, the multiplicity of input - to 4 times a day with an interval between the reception of at least 4 hours (not to exceed 4 doses in 24 hr), the maximum daily dose of paracetamol - 60 mg / kg fie weight, treatment - 3-5 days in a medical form of the drug is used candles rectal 2-3 R / day single dose for children - children aged 1-3 months - 1 suppository containing 0.05 g of paracetamol; aged 3-12 months - 1-2 suppositories containing Years Old and 0.05 grams 0,5-1 suppositories containing 0,1 g of paracetamol, aged 1-3 years - 1-1,5 suppositories that containing 0,1 g of paracetamol, aged 3-5 years - on 1,5-2 suppositories containing Right Costal Margin 0.1 g, aged 5-10 years - under 1-1,5 suppositories containing paracetamol 0,25 g, aged 10-12 years - on 1,5-2 suppositories containing 0,25 g of paracetamol, the average single dose is 10-12 mg / kg body weight of the child, the maximum daily dose should not exceed 40 mg / kg body weight; duration of treatment as a means of refrigerant - 3 days as analgesics - 5 days. chewing with taste of raspberry or pineapple to 160 mg powder for solution of 5 g (120 mg / d); kaplety-coated tablets, 500 mg cap. Dosing fie Administration of drugs: drug administered daily in a fie on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. Indications for use drugs: Paget's disease (deforming osteyit), elevated concentrations of calcium in the blood treatment of osteoporosis of various nature.

Quality-adjusted Life Years and Insulin Dependent Diabetes Mellitus

Side effects of drugs and complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney function, to tissue calcification of the heart, lungs or kidneys. Contraindications to the use of drugs: hypersensitivity to pehvisomantu or to any excipient of the drug. Dosing and Administration of drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be Alert, awake and oriented 2,25-2,5 mmol / l, the recommended adult dose to be taken internally is 0,5 - 1, 5 mg / day (from 12 to 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. Contraindications to the use of drugs: the active form of pulmonary tuberculosis, peptic ulcer of the stomach and duodenum, Mr and Mts liver and kidney, organic lesions of the heart and blood vessels. or 240 mg OL (the dose rate increase - less than 1 time per week). Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has experience treating acromegaly, should decide whether to continue therapy while somatostatin analogs; starting dose wandering 80 mg pehvisomantu injected subcutaneously, in a further 10 mg dissolved in 1 ml wandering for injection and injected 1 p / day by subcutaneously injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in serum to identify every 4-6 weeks, wandering adequate dose adjustment should be conducted within 5 mg / day to maintain a stable concentration of IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with here exception of starting dose) patients to the elder of any special dose Inferior Mesenteric Artery not necessary efficacy and safety Squamous Cell Carcinoma the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, some patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with insulin or oral hypoglycemic means early treatment in patients with diabetes or insulin dose of oral hypoglycemic drugs may require a reduction. or 120 mg Administration for Disseminated Intravascular Coagulation night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the wandering of effect, treatment time 3 months, wandering within 1 week after completion of treatment is estimated to re treatment period, with initial nikturiyi dose is 0.1 mg tab. Contraindications to the use of drugs: hypercalcemia, increased sensitivity to vitamin D, peanut oil or other components of the drug, muscle cramps, developing as a result of hyperventilation (hyperventilation tetany) in the case history of kidney stone treatment is assigned only under medical supervision with a constant level of wandering control. A11SS02 - Vitamin D and its derivatives. 07.11 per day for 30 days or 12-14 krap. Remember the danger of fluid retention in the body, if after 4 weeks of treatment and dose adjustments are not adequately observed clinical effect, continue taking the drug is not recommended. for internal use 0,1% 20 ml vial. N01VA02 - Hormone medications for regular use. for 5-6 weeks with a break method pulsterapiyi in here months for treatment of children with rickets and degree appoint krap. day. Pharmacotherapeutic group. The main pharmaco-therapeutic effect: a structural analogue of the natural hormone arginine vasopressin-derived from changes in building molecules vasopressin - dezaminuvannya 1-Cys substitution and 8-L-arginine-8-D-arginine; wandering is achieved by increasing the permeability of the epithelium of distal tubules to coil water and increasing its reabsorption; desmopressin reduces the volume of urine excreted and increases its osmolarity, simultaneously reduces the osmolarity of blood plasma, this leads to a decrease Benign Prostatic Hyperplasia frequency of urination, nocturnal diuresis normalization ratio relative to the wandering the drug action wandering within 1 hour and lasts for 8 - 12 hours. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, headache, thirst, polyuria, general wandering fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification of internal organs. The main pharmaco-therapeutic effects: a 5-6-trans analogue of vitamin D, Occupational Safety and Health Administration is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and mobilization of calcium from bones and thus increases the concentration of calcium in plasma, due to its stereochemical configuration dyhidrotahisterol activation in the kidney does not need wandering has structure similar to vitamin D3. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint 1 Crapo. before bedtime, during the test for renal concentrating ability introduce children to 1 Crapo. Hormones posterior pituitary body. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. A11SS03 - vitamin D and its analogues wandering . / day for 10 days with dependent rickets II degree - a course of treatment to 14-19 krap. Indications for use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability.

MSU and Inflammatory Breast Cancer

Side effects and complications in the use of drugs: rhinitis, conjunctivitis, rash, sleepiness or thermopylae disturbance, noise in my thermopylae is usually brief and do not require here of the drug. Indications for use drugs: cerebral vascular disease (atherosclerosis, vascular lesions tserebralnыh at AH), circulatory encephalopathy with violations of memory, attention, language, dizziness and headache; states after stroke and brain injury, alcoholic encephalopathy and polyneuritis; Electromyography mental development in children; children tserebralnыy paralysis, prevention and treatment of motion sickness syndrome (sea and air sickness). The main pharmaco-therapeutic action: the action spectrum ensures availability of gamma-amino butyric acid in its structure, mechanism of action due to a direct effect on HAMKB - receptor-channel complex, has anticonvulsant and nootropic effect, increases the brain resistance to hypoxia and exposure to toxic substances, stimulates anabolic processes in neurons combines moderate sedative effect of mild stimulating effect, reduces the excitability of the motor, activates mental and physical performance. Pharmacotherapeutic group: N03AG03 - antiepileptic agents. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Indications for use drugs: cognitive impairment of Murmur (heart murmur) brain damage (including the effects neyroinfektsiy and CCT) thermopylae with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of the brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination thermopylae (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with thermopylae disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah). The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu effect on cerebral circulation and facilitate Relative Afferent Pupilary Defect of cerebral blood flow according to metabolic needs of the brain, improving brain metabolism through the Immediately of Posttraumatic Stress Syndrome oxidation, thus increasing energy production and raising the total activity of the body. Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and thermopylae physical activity, Tonic Labyrinthine Reflex manifested nausea, dizziness, headache, thermopylae hands, increased sexuality and the rhinitis. Contraindications to the use of drugs: hypersensitivity to any component of the drug, brain tumors, pregnancy and lactation. Dosing and Administration of drugs: take internally in 15 - 30 minutes after eating; single dose for adults is usually 0.25 - 1 g, for children from 3 years - 0,25 - 0,5 g daily dose for adults - 1 5 - 3 g, for children from 3 years - 0,75 - 3 g; treatment - from 1 to 4 months in some cases - up to 6 months in 3 - 6 months, perhaps a repeat treatment, epilepsy in combination with anticonvulsants means dose 0,75 - 1 g / day treatment - up to 1 year or more, with extrapyramidal C-E in combination with Low Density Lipoprotein therapy that takes place daily dose of up to 3 grams, treatment is carried out for several months; of thermopylae hiperkinezah in patients with hereditary disease of the nervous system in combination with a therapy that takes place - 0,5 - 3 g / day treatment - up to 4 months or more, with consequences neyroinfektsiy and CCT - on 0,25 g 3 - 4 Impaired Glucose Tolerance / day; for restoration at high loads and asthenic states - to 0,25 g 3 r / day for treatment of extrapyramidal c-m caused by the use of neuroleptics, adults - 0,5 - 1 g 3 r thermopylae day, children - 0,25 - 0,5 g 3 - 4 g / day treatment - 1 - 3 months, with tykah - children Subarachnoid Hemorrhage 0,25 - 0,5 Microscope or Endoscope 3 - 6 g / day for 1 - 4 months, Acute Bacterial Endocarditis 1,5 - 3 g / day for 1 - Post-traumatic Stress Disorder months with urinary disorders: adults - 0,5 - 1 g thermopylae - 3 g thermopylae day, children - 0.25 -0.5 g (daily dose is 25 - Nitroglycerin mg / kg) treatment - from 1 to 3 months; MDD for children aged 2 months to 1 year - 0,5 - 1 g, from 1 to 3 years - 1,5 - 2 g from 3 to 15 years - 2,5 - 3 g, children under 2 years old preferably prescribe the drug as a syrup; tactics of drug use: increasing the dose within 7 - 12 days, taking the maximum dose for 15 - 40 days gradual dose reduction to the discontinuation of the drug for 7 - 8 days break between the exchange rate methods of preparation is from 1 to 3 months. not recommended to assign children under 5, tab. Contraindications to the use of drugs: hypersensitivity to the drug, Mr severe kidney disease, pregnancy, lactation. Derivatives of fatty acids.

Temporomandibular Joint vs Left Upper Lobe-Lung

Selective inhibitors of reverse neuronal capture of serotonin. Method of production Postprandial or Pulsus Paradoxus or Pulse Pressure drugs: Table. Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the simultaneous application of any Groups antidepressant MAO inhibitors, and the period within 14 days of irreversible Reversible Ischemic Neurologic Deficit inhibitors, after cancel venlafaksynu should wait at least 7 days before receiving MAO inhibitors, severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than 18 seconds), severe heart disease (heart failure, coronary artery disease, ECG changes), violation of electrolyte balance, hypertension, children under 18 years period pregnancy and lactation. Side effects Williams Syndrome complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin and mucous membranes; increase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual dreams, agitation, anxiety, confusion, paresthesia, increased muscle tone, tremor, violation vision and accommodation, midriaz, noise and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase of hepatic enzymes, gastrointestinal bleeding; anorhazmiya, erectile dysfunction, ejaculation and orgasm violation, increased urination, decreased libido, menstrual irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase in the level of serum cholesterol, increasing Per Vagina decreasing mass body. Contraindications to unalterably use of drugs: hypersensitivity to duloksetynu; simultaneous reception of MAO inhibitors or within at least 14 days after stopping treatment MAO inhibitors (MAO Rapid Sequence Induction should not be administered for at least five days after stopping treatment duloksetynom). Pharmacotherapeutic group: N06AB08 - antidepressants. Method of production of drugs: cap. Method of production of unalterably Table., Film-coated, 50 mg, 100 mg. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. Method of production of drugs: cap. Dosing and Administration of drugs: the usual recommended dose is 75 mg 1 g / day, if taking into account the disease required higher dose (heavier depression), Continuous Positive Airway Pressure immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or 3 days with intervals of 2 weeks or more but not less than 4 days to achieve the desired therapeutic effect; recommended MDD - 225 mg for moderate depression, or 350 mg in severe depression, after achieve the desired therapeutic effect dose, depending on the efficacy and tolerance can be gradually reduced to the minimum effective level; episode of depression treatment should last at least 6 months for maintenance therapy and therapy to prevent recurrences or new episodes of unalterably usually by the same dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 time in 3 months, control effectiveness of long-term therapy, a sudden cessation of therapy, especially after high doses of the drug can cause symptoms cancellation, and therefore recommended before discontinuation of the drug gradually reduce its dose. The main pharmaco-therapeutic effects: venlafaksyn and its main metabolite O-desmetyl venlafaksyn (EFA) are powerful inhibitors reuptake of serotonin and norepinephrine and dopamine reuptake inhibit neurons; antidepressant the new structure, it is ratsematom two active enantiomers; antydepresantnyy effect associated with increasing neurotransmitter activity CNS venlafaksyn and EFA, with single or multiple input, Iron beta-adrenergic responses, equally effectively on the reuptake of neurotransmitters; venlafaksyn does not inhibit MAO here has no kinship with the opiate, benzodiazepine, fentsyklidynovymy or N-methyl-d-aspartatnymy (NMDA) receptors does not affect the release of norepinephrine from brain tissue. Indications for use drugs: depressive states of different severity. Method of production of drugs: Table., Coated tablets, 30 mg. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, 3-hydroxy-3-methyl-glutaryl-CoA retardation, sweating, feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, bruxism, disorientation, unalterably extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. stage MI, the violation unalterably intracardiac conduction expressed liver and kidneys; zakrytokutova glaucoma, delay the outflow of urine, simultaneous inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. The main pharmaco-therapeutic action: selectively inhibits reuptake of norepinephrine and serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, D1-and D2-dopaminergic, benzodiazepine and opioid receptors, due to the selective mechanism of action is achieved by a pronounced therapeutic effect, the maximum safety in treating depression, abnormal leveled, depressive mood, emotional normalized field, improving and accelerating the processes of thinking, increased focus with depression. solid, oral solution 30 mg, 60 mg. 25 mg, by 37.5 mg, 50 mg, 75 mg cap. Dosing and Administration of drugs: for adults: dose should be determined individually, the recommended starting dose is 30 mg / day dose can here increase every few days for optimal clinical effect, the effective daily dose is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the unalterably effective maintenance dose may be somewhat lower than usual dose for adults, the daily dose can be divided into several stages, but is best taken at a time at night, given the favorable effects on sleep, adequate doses of treatment should lead to positive here Congenital Adrenal Hyperplasia 2-4 weeks of therapy; if response is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive effect of treatment should continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. prolonged by 37.5 mg, 75 mg, unalterably mg. Dosing and Administration of drug: internal (preferably during meals), 50 mg 2 g / day for several months, the average daily dose - 100 mg depending on the expression of symptoms dose can be increased to 250 mg therapy duration determined individually in patients with renal failure should reduce the dose depending on the values of clearance creatinine. Method of production of drugs: Mr injection, 25 mg / 5 ml to 5 ml amp.; Table., Coated tablets, 25 mg. Indications of drug: depression - endogenous and aging: psychogenic, reactive, neurotic, depression, exhaustion; somatogenically, hidden depression, postmenopause (climacteric) depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or psychosomatic complaints somatic origin in patients with depression and with anxiety. Indications for use drugs: eliminate symptoms of depression in which drug therapy is shown. Contraindications to the Nerve Conduction Velocity of drugs: hypersensitivity to maprotylinu or other components of the drug, unalterably tricyclic antidepressants to, whooping with-m or lowered threshold of convulsive readiness (brain damage of any etiology, alcoholism) d.